Intercept Pharmaceuticals, Inc.

CITADEL ADVISORS LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

81,972

Value ($000)

1,520

Weight

0.0%

2014 Q1 - 2023 Q3 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	1,520	0.0%	81,972	9/30/2023
2023 Q2	8/14/2023	916	0.0%	82,818	6/30/2023
2023 Q1	5/15/2023	2,148	0.0%	159,959	3/31/2023
2022 Q4	2/14/2023	5,902	0.0%	477,129	12/31/2022
2022 Q3	11/14/2022	5,064	0.0%	363,061	9/30/2022
2022 Q2	8/15/2022	1,778	0.0%	128,784	6/30/2022
2022 Q1	5/16/2022	281	0.0%	17,231	3/31/2022
2021 Q4	2/14/2022	192	0.0%	11,784	12/31/2021
2021 Q3	11/15/2021	161	0.0%	10,819	9/30/2021
2021 Q2	8/16/2021	1,664	0.0%	83,316	6/30/2021
2021 Q1	5/21/2021	16,852	0.0%	730,128	3/31/2021
2020 Q4	2/16/2021	5,422	0.0%	219,539	12/31/2020
2020 Q3	11/16/2020	7,239	0.0%	174,590	9/30/2020
2020 Q2	8/14/2020	8,786	0.0%	183,385	6/30/2020
2020 Q1	5/15/2020	9,181	0.0%	145,828	3/31/2020
2019 Q4	2/14/2020	23,273	0.0%	187,812	12/31/2019
2014 Q1	5/15/2014	3,784	0.0%	11,474	3/31/2014